Table 2.
Crude |
Model I‡ |
Model II§ |
||||
---|---|---|---|---|---|---|
Mean ACR (95% CI) N | p Value | Mean ACR (95% CI) N | p Value | Mean ACR (95% CI) N | p Value | |
Morbid sample | 0.013* | 0.13* | 0.11* | |||
No headache | 2.03 (1.92 to 2.14) 3998 | 1.96 (1.85 to 2.07) 3998 | 1.96 (1.85 to 2.06) 3978 | |||
Non-migraine headache | 1.95 (1.68 to 2.23) 591 | 0.61† | 2.26 (1.97 to 2.54) 591 | 0.057† | 2.27 (1.99 to 2.55) 585 | 0.044† |
Migraine | 1.22 (0.68 to 1.75) 159 | 0.003† | 1.85 (1.31 to 2.40) 159 | 0.70† | 1.87 (1.33 to 2.41) 158 | 0.75† |
Random sample | 0.011* | 0.60* | 0.55* | |||
No headache | 1.22 (1.11 to 1.32) 1289 | 1.16 (1.06 to 1.27) 1289 | 1.16 (1.05 to 1.26) 1285 | |||
Non-migraine headache | 0.96 (0.77 to 1.14) 418 | 0.017† | 1.08 (0.89 to 1.26) 418 | 0.44† | 1.07 (0.89 to 1.26) 417 | 0.44† |
Migraine | 0.85 (0.53 to 1.16) 144 | 0.028† | 1.02 (0.70 to 1.34) 144 | 0.41† | 1.00 (0.68 to 1.31) 143 | 0.35† |
*p Value for overall effect of headache groups.
†p Values are for comparison against no headache group within the same selection criterium.
‡Model I: adjusted for age and sex.
§Model II: adjusted for age, sex, self-reported diabetes and self-reported use of antihypertensive medication.